Life Science Instrumentation Market Scope
Life Science Instrumentation is mainly used in research and development activities in various laboratories such as industrial, biotechnology, pharmaceutical, and academic institutes. These instruments also can be used for testing of quality food products and monitor & control process in manufacturing plants. Life Science Instrumentation plays an important role in the scientific examination of a living organism in biotechnology and molecular biology. Due to favorable government policies for pharmaceutical R&D in emerging nations will drive the market of life science instruments in forecasted years.
The market study is being classified by Type (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR and Microscopy), by Application (clinical Application and Diagnostic Applications) and major geographies with country level break-up.
Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Life Science Instrumentation market throughout the predicted period.
Thermo Fisher Scientific, Inc. (United States), Danaher Corporation (United States), Agilent Technologies, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Bruker Corporation (United States), PerkinElmer, Inc. (United States), Waters Corporation (United States), Shimadzu Corporation (Japan), Illumina, Inc. (United States) and Siemens AG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Horiba Ltd. (Japan), Bio-Rad Laboratories, Inc. (United States), Abbott Laboratories (United States), Becton, Dickinson and Company (United States) and Hitachi High-Technologies Corporation (Japan).
AdvanceMarketAnalytics has segmented the market of Global Life Science Instrumentation market by Type, Application and Region.
On the basis of geography, the market of Life Science Instrumentation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Research Institutes will boost the Life Science Instrumentation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
“According to EU GMP (European Union's), it’s denoted that, the products related to life science instrumentation must be updates with applied retrospectively, which means that scientific instruments that have already been validated might not be in compliance today. It might, therefore, be necessary to re-evaluate the compliance state of your scientific instruments.”
- Increasing Adoption of Hyphenated Technologies
- Adoption of New Technologies in Analytical Instruments
- Increasing Spending on Pharmaceutical R&D
- Growing Food Safety Concerns Globally
- Increasing Public-Private Investments in Life Science Research
- Growth Opportunities For the Pharmaceutical and Biotechnology Industry
- in Emerging Countries
- Rising Demand for Analytical Instruments in Proteomics
- High Cost of Instruments
- Lack of Skilled Professionals
- Insufficient Infrastructure for Research in Emerging Countries
Key Target AudienceLife science instrumentation manufacturers, Pharma & biotech companies and CROs, Academic institutions and private research institutions, Environmental testing laboratories, Food and beverage testing centers, Hospitals and diagnostic centers and Service laboratories
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase